FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
01/17/2025
Back to search
Official data from USPTO
PHYTRICARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
PHYTRICARE
ST13
US500000079366121Class
5, 31
Filing
79366121
Registration
7445250
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
01/17/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 31
Filing date
11/29/2022
Registration date
07/16/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/16/2024
Last transaction
01/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
DE
Examiner
HAN, DAWN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Evonik Operations GmbH
Representatives
Scott D. Woldow Smith, Gambrell & Russell, LLP
Technical classification
Nice Classes
Class 5Class 31
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for treating inflammation conditions and metabolic conditions; pharmaceutical preparations for nutritionnutritional supplements; veterinary preparations for treating inflammation conditions and metabolic conditions; veterinary preparations for nutritionnutritional supplements for veterinary purposes; medical preparations for the treatment of inflammation conditions and metabolic conditions; medical preparations for nutrition chemical preparations for nutritionnutritional supplements for medical purposes; medicated additives for animal foodsanimal feed additives for use as nutritional supplements for medical purposes; additives with medicinal effects for feedanimal feed additives for use as nutritional supplements for medical purposes; chemical preparations for inflammation conditions and metabolic conditions for medicalpharmaceutical and veterinary purposes; chemical preparations for nutritionnutritional supplements for medicalpharmaceutical and veterinary purposes; medicated animal feed; medicated supplements for animal feedstuffs; amino acids for medical and veterinary purposes; cellulose esters for pharmaceutical purposesmedicinal oils and greases for medical and veterinary purposes; salt productspotassium iodide and sodium salts for medical purposes; steroids; biological preparations for the treatment of metabolic disorders for medical and veterinary purposes; ferments for pharmaceutical purposes; yeast dietary supplements; yeast for pharmaceutical purposes; starch for pharmaceutical purposes; enzymes and enzyme preparationsall for medical and veterinary purposes; bacterial preparations for medical and veterinary purposes; bacteriological preparations for medical and veterinary purposes; cultures of microorganisms for medical and veterinary use; nutritive substances for microorganisms for medical purposes; bouillons for bacteriological cultures for medical or veterinary purposes; probiotic supplements; probiotic bacterial preparations for veterinary use; probiotic preparations for medical use featuring bacterial formulations; probiotic supplements for dietetic use; food supplements in the nature of antioxidants; sanitary preparations for medical purposes; dietetic foods adapted for medical and veterinary use; dietetic preparations adapted for medical purposes; dietetic animal foodstuffs for medical purposes; nutritional supplements; albuminous dietetic preparations adapted for medical purposes; medicated confectionery; medicinal drinks; dietetic beverages adapted for medical purposes; dietetic preparations adapted for medical use; medical preparations for slimming purposes; nutritional supplements for humans; dietary supplements for animals; dietetic preparations adapted for medical purposes and for use as dietary supplements; sugar in the nature of candy and glucose for medical purposes; glucose for medical purposes; dietetic albuminous animal foodstuffs for medical purposes; protein dietary supplements; dietary fibre to aid digestion; mineral food supplements; nutritional preparationsnutritional supplements containing trace elements for human and animal use; vitamin preparations; feed supplements in the nature of amino acids for veterinary purposessynthetic peptides for the treatment of inflammationmetabolic conditionsnutrition deficiencyprotein supplements for use in animal feedfish food and aquacultures; animal feed supplementsnot for medical purposes; nutritional supplementsflavonoids for use as a dietary supplement
Class 31
Products for aquacultureaquaculture feed; live animals; foodstuffs and fodder for animals; preparations for use as animal feed; foodstuffs for fish; aquaculture feed; foodstuffs for animals containing botanical extracts; yeast for animal consumption
Publications
History of USPTO decisions and trademark events.
35 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/27/2024
FIMP
FINAL DISPOSITION PROCESSED
12/27/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/17/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/16/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
07/16/2024
GPNX
NOTIFICATION PROCESSED BY IB
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/30/2024
PUBO
PUBLISHED FOR OPPOSITION
04/30/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/10/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/10/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
04/10/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/25/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/25/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/25/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/25/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
03/18/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/18/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
03/18/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/18/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
03/18/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/18/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/18/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/18/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/18/2024
RFNT
REFUSAL PROCESSED BY IB
08/29/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/04/2023
RFRR
REFUSAL PROCESSED BY MPU
08/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2023
CNRT
NON-FINAL ACTION WRITTEN
06/27/2023
DOCK
ASSIGNED TO EXAMINER
06/19/2023
MAFR
APPLICATION FILING RECEIPT MAILED
04/04/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/30/2023
Continuous trademark protection
Get notified about every new filing that threatens PHYTRICARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.